Literature DB >> 8943484

Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney.

Y Xu1, J Hagege, B Mougenot, J D Sraer, E Rønne, E Rondeau.   

Abstract

Renal thrombotic microangiopathy is characterized by glomerular and vascular thrombosis. The persistancy of fibrin deposits may result from imbalance between plasminogen activation and inhibition. In the present study, we used immunohistochemistry and in situ hybridization techniques to determine the localization of urokinase-type (u-PA) and tissue-type (t-PA) plasminogen activators, type 1 plasminogen activator inhibitor (PAI-1) and membrane receptor for u-PA (uPA-R) antigen and their sites of synthesis in renal thrombotic microangiopathy (N = 10) as compared to acute tubular necrosis (N = 5) and normal human kidneys (N = 7). We found an induction of PAI-1 and uPA-R expression in glomeruli and in arterial walls in renal thrombotic microangiopathy. In addition, the induction of uPA-R expression was also found in some tubular epithelial cells. In most case, local synthesis of PAI-1 and uPA-R was confirmed by in situ hybridization with the corresponding cDNA probes. In contrast, using similar techniques PAI-1 and uPA-R antigens and messenger RNAs could not be detected in normal kidneys. In both renal thrombotic microangiopathy and normal kidneys, t-PA mRNA was detected in large amounts in all glomeruli and in vascular endothelial cells, but t-PA antigen was only detected in a limited number of glomerular and arterial endothelial cells, whereas it was strongly expressed by all venous endothelial cells. Although u-PA antigen was found in almost all tubular sections, u-PA mRNA was only found in tubular epithelial cells in the deep cortex and the outer medulla. Our results indicate that there is an up-regulation of PAI-1 and u-PA-R expression in the glomeruli and in the arterial walls of thrombotic microangiopathy. The local release of PAI-1 could play a role in the persistancy of fibrin deposition and the further development of fibrotic lesions. Whether uPA-R plays a pathogenic role in the development of glomerular and vascular lesions, or is involved in the repair process of these lesion, remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943484     DOI: 10.1038/ki.1996.523

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  How tubular epithelial cells dictate the rate of renal fibrogenesis?

Authors:  Kevin Louis; Alexandre Hertig
Journal:  World J Nephrol       Date:  2015-07-06

2.  Plasminogen activator inhibitor type 1 expression induced by lipopolysaccharide of Porphyromonas gingivalis in human gingival fibroblast.

Authors:  Hee Sam Na; Eun J Lim; So Y Jeong; Mi H Ryu; Mi Hee Park; Jin Chung
Journal:  J Microbiol       Date:  2014-02-01       Impact factor: 3.422

3.  Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.

Authors:  Namiko Kobayashi; Toshiharu Ueno; Kumi Ohashi; Hanako Yamashita; Yukina Takahashi; Kazuo Sakamoto; Shun Manabe; Satoshi Hara; Yasutoshi Takashima; Takashi Dan; Ira Pastan; Toshio Miyata; Hidetake Kurihara; Taiji Matsusaka; Jochen Reiser; Michio Nagata
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

Review 4.  Loss of heparin-binding protein prevents necrotizing glomerulonephritis: first clues hint at plasminogen activator inhibitor-1.

Authors:  Delia Lidia Şalaru; Peter R Mertens; Peter Bartsch
Journal:  Int Urol Nephrol       Date:  2013-03-30       Impact factor: 2.370

5.  Plasma concentration of urokinase plasminogen activator receptor is a marker of kidney allograft function.

Authors:  Marzena Staniszewska; Violetta Dziedziejko; Ewa Kwiatkowska; Marta Tkacz; Kamila Puchałowicz; Krzysztof Safranow; Leszek Domanski; Andrzej Pawlik
Journal:  Ir J Med Sci       Date:  2018-03-01       Impact factor: 1.568

Review 6.  Physiology and pathophysiology of the plasminogen system in the kidney.

Authors:  Per Svenningsen; Gitte Rye Hinrichs; Rikke Zachar; Rikke Ydegaard; Boye L Jensen
Journal:  Pflugers Arch       Date:  2017-06-27       Impact factor: 3.657

7.  Plasmin in nephrotic urine activates the epithelial sodium channel.

Authors:  Per Svenningsen; Claus Bistrup; Ulla G Friis; Marko Bertog; Silke Haerteis; Bettina Krueger; Jane Stubbe; Ole Nørregaard Jensen; Helle C Thiesson; Torben R Uhrenholt; Bente Jespersen; Boye L Jensen; Christoph Korbmacher; Ole Skøtt
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

8.  "Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression".

Authors:  Michaela Muth; Katharina Theophile; Kais Hussein; Christoph Jacobi; Hans Kreipe; Oliver Bock
Journal:  J Transl Med       Date:  2010-04-01       Impact factor: 5.531

9.  Protease activated receptor 2 in diabetic nephropathy: a double edged sword.

Authors:  Arnold C Spek; Maaike Waasdorp; JanWillem Duitman; Sandrine Florquin; C Arnold Spek
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

10.  Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS).

Authors:  Friedrich Modde; Putri Andina Agustian; Juliane Wittig; Maximilian Ernst Dämmrich; Vinzent Forstmeier; Udo Vester; Thurid Ahlenstiel; Kerstin Froede; Ulrich Budde; Anne-Margret Wingen; Anke Schwarz; Svjetlana Lovric; Jan Thomas Kielstein; Carsten Bergmann; Nadine Bachmann; Mato Nagel; Hans Heinrich Kreipe; Verena Bröcker; Clemens Luitpold Bockmeyer; Jan Ulrich Becker
Journal:  Virchows Arch       Date:  2013-03-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.